Real Test ABVM-ENDO Mock Exam
Killexams.com delivers the most current and 2026 updated Pass4sure ABVM-ENDO free questions TestPrep, featuring test prep questions Q&A tailored to the latest syllabus of the APCA ABVM-ENDO Exam. Engage with their ABVM-ENDO test prep questions practice test Q&A to deepen your knowledge and achieve high marks. They ensure your triumph at the Test Center by covering all test references and building your confidence with the ABVM-ENDO test. Succeed with their ABVM-ENDO Mock Exam preparation tools.

In 2026, significant enhancements and updates were made to ABVM-ENDO, all of which are seamlessly integrated into their Exam Cram TestPrep. Their 2026 updated ABVM-ENDO practice questions guarantee your success in the genuine exam. They strongly advise reviewing the entire examcollection at least once before the real test. This is not only due to the effectiveness of their ABVM-ENDO Free Practice Practice Test, but also because candidates experience a notable boost in their knowledge. This empowers them to excel as professionals in real-world organizational settings. At Killexams.com, their focus extends beyond merely passing the ABVM-ENDO test with their Practice Tests; they aim to deepen your understanding of ABVM-ENDO syllabus and objectives, paving the way for true success.

We offer authentic ABVM-ENDO test Q&A MCQs in two versatile formats: ABVM-ENDO PDF files and ABVM-ENDO VCE test simulator. Pass the APCA ABVM-ENDO test swiftly and effectively with their materials. The ABVM-ENDO MCQs PDF format is compatible with any device, and you can print ABVM-ENDO Free Practice practice questions to create your personalized study guide. Their pass rate stands at an impressive 98.9%, with a 98% similarity rate between their ABVM-ENDO study guide and the genuine exam. Ready to ace the ABVM-ENDO test on your first try? Visit Killexams.com for the APCA ABVM-ENDO real test resources now.

Exam Code: ABVM ENDO
Exam Name: American Board of Vascular Medicine Endovascular Medicine
Number of Questions: 135 multiple-choice questions.
Time Allotted: 180 minutes (3 hours)
Passing Score: 300 to 700

To pass, you must achieve a scaled score of at least 555.

- Pathophysiology, Risk Factors, and Screening
- Pathophysiology
- Arterial Diseases: Atherosclerosis, plaque rupture, thrombosis, intimal hyperplasia, restenosis, aneurysm formation, dissection.
- Venous Diseases: Venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), chronic venous insufficiency (CVI), varicose veins, post-thrombotic syndrome.
- typical Vascular Disorders: Fibromuscular dysplasia (FMD), vasculitis (e.g., Takayasu, giant cell arteritis), Buerger's disease, Raynaud's phenomenon, popliteal entrapment - drome, cystic adventitial disease.
- Lymphatic Diseases: Lymphedema (primary/secondary), lymphangitis.

- Epidemiology and Risk Factors
- Arterial: Smoking, diabetes, hypertension, hyperlipidemia, age, family history, chronic kidney disease.
- Venous: Immobility, surgery, cancer, hypercoagulable states (Factor V Leiden, antithrombin deficiency), oral contraceptives.

- Clinical Standards for Screening
- Ankle-brachial index (ABI) thresholds, abdominal aortic aneurysm (AAA) screening in men >65 with smoking history, carotid screening in high-risk patients.

- Atherosclerosis, thromboembolism, Virchow's triad, Rutherford classification (for PAD), CEAP classification (for venous disease).

- Diagnosis and Testing
- History and Physical Exam
- Arterial: Claudication, critical limb ischemia (CLI), rest pain, tissue loss; pulses (femoral, popliteal, pedal), bruits, dependent rubor, ulcers.
- Venous: Leg swelling, pain worse with dependency, varicose veins, stasis dermatitis, ulcers (medial malleolus).
- Atypical: String-of-beads appearance (FMD), livedo reticularis (vasculitis).
- Lymphatic: Pitting/non-pitting edema, Stemmer's sign.

- Differential Diagnosis, Imaging, and Laboratory Evaluation
- Arterial: Duplex ultrasound, CTA/MRA, angiography; ABI, toe-brachial index (TBI), pulse volume recordings (PVR).
- Venous: Duplex for reflux/DVT, venography, intravascular ultrasound (IVUS).
- Atypical: Specific imaging for vasculitis (PET-CT), entrapment (provocative maneuvers).

- Duplex ultrasound (reflux >0.5-1s), ABI <0.9 (PAD), D-dimer, Wells score (DVT/PE), TASC classification (aortoiliac lesions).

- Treatment and Interventions
- Endovascular Interventions and Surgery
- Arterial: Angioplasty (PTA), stenting (self-expanding, balloon-expandable, drug-eluting, covered), atherectomy (directional, orbital, laser), thrombolysis/catheter-directed therapy (CDT).
- Sites: Aortoiliac, femoropopliteal, tibial, renal, carotid, subclavian.
- Aneurysm: EVAR (endovascular aneurysm repair), fenestrated/branched grafts.

- Venous: Venous stenting (iliac veins for May-Thurner), IVC filter placement/retrieval, venous ablation (radiofrequency, laser), sclerotherapy.
- Atypical: Embolization for aneurysms/malformations, stenting for FMD/entrapment.

- Procedural Complications
- Arterial: Dissection, perforation, embolization, access site hematoma, contrast-induced nephropathy (CIN), radiation injury.
- Venous: Thrombosis post-stenting, filter migration/fracture, pulmonary embolism during intervention.
- Atypical: Compartment syndrome, reperfusion injury.

- Medical Treatment
- Arterial: Antiplatelets (aspirin, clopidogrel), statins, cilostazol, anticoagulation (DOACs, warfarin).
- Venous: Anticoagulation (heparin, DOACs), compression therapy.
- Atypical: Immunosuppression for vasculitis.
- Lymphatic: Compression garments, manual lymphatic drainage.

- Clinical Guidelines for Intervention
- Indications per SVS/ESVS/ACC guidelines: CLI vs. lifestyle-limiting claudication, TASC II/III lesions, chronic total occlusions (CTO).

- Chronic total occlusion (CTO), drug-coated balloon (DCB), intravascular ultrasound (IVUS), thrombolysis (tPA), dual antiplatelet therapy (DAPT), Rutherford/Boland categories, Fontaine stages.

- Prognosis, Surveillance, and Re-intervention
- Arterial: Patency rates (primary/secondary), limb salvage, amputation-free survival; duplex surveillance post-EVAR/stenting.
- Venous: Post-thrombotic syndrome risk, recurrence rates.
- Atypical: Disease progression in vasculitis/FMD.

- Endoleak (Types I-V post-EVAR), in-stent restenosis (ISR), target lesion revascularization (TLR), duplex criteria for restenosis (>50% velocity ratio >2-3).